IV iron therapy significantly lowers the risk of hospitalization in heart failure patients with iron deficiency, improving outcomes and quality of life.

A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Germany: A recent systematic review and meta-analysis published in Nature Medicine highlighted the benefits of intravenous ...

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...

Single-dose IV iron is a fast, effective treatment for maternal IDA, enhancing recovery with fewer side effects. Learn more.

A new study published in the Turkish Journal of Hematology showed that ferric carboxymaltose may raise hemoglobin and ...